{"id":"hydroxyethylstarch-6-130-0-4","safety":{"commonSideEffects":[{"rate":null,"effect":"Acute kidney injury"},{"rate":null,"effect":"Coagulopathy / increased bleeding"},{"rate":null,"effect":"Hyperchloremic acidosis"},{"rate":null,"effect":"Anaphylaxis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"HES is a starch-based plasma volume expander composed of glucose polymers with a molecular weight of 130 kDa and degree of substitution of 0.4. It functions as a colloid, drawing and retaining fluid within the intravascular compartment to restore circulating blood volume and improve tissue perfusion during hypovolemia. The 0.4 substitution ratio indicates moderate hydroxyethylation, which affects the molecule's persistence in circulation and metabolic degradation.","oneSentence":"Hydroxyethylstarch (HES) 6% 130/0.4 is a synthetic colloid that expands intravascular volume by increasing plasma oncotic pressure and maintaining fluid in the vascular space.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:41:04.712Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hypovolemia and restoration of circulating blood volume in perioperative and critical care settings"}]},"trialDetails":[{"nctId":"NCT07410988","phase":"PHASE4","title":"Hydroxyethyl Starch Versus Crystalloid and Postoperative Major Adverse Kidney Complications","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2026-04-01","conditions":"Cardiac Surgery","enrollment":1292},{"nctId":"NCT05435573","phase":"NA","title":"Cardiac Output in Preeclamptic","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2022-08-17","conditions":"Echocardiography","enrollment":34},{"nctId":"NCT06663254","phase":"PHASE4","title":"Safety and Efficacy of Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery","status":"NOT_YET_RECRUITING","sponsor":"Xiangya Hospital of Central South University","startDate":"2024-11-30","conditions":"Perioperative Volume Replacement, Hydroxyethyl Starch","enrollment":410},{"nctId":"NCT04465539","phase":"NA","title":"The Potential Therapeutic Role of Hydroxyethyl Starch and Hydrocortisone in Acute Aluminum Phosphide Poisoning","status":"COMPLETED","sponsor":"Tanta University","startDate":"2020-07-15","conditions":"Potential Therapeutic Role","enrollment":60},{"nctId":"NCT05475886","phase":"NA","title":"6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension","status":"UNKNOWN","sponsor":"General Hospital of Ningxia Medical University","startDate":"2024-02-01","conditions":"Adverse Effect","enrollment":40},{"nctId":"NCT05712018","phase":"NA","title":"Comparison of Different HES Coload Volumes on the 90% ED of Norepinephrine","status":"COMPLETED","sponsor":"General Hospital of Ningxia Medical University","startDate":"2023-10-20","conditions":"Adverse Effect","enrollment":90},{"nctId":"NCT02882074","phase":"NA","title":"Endothelial Function After Cardiac Surgery","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-06","conditions":"Endothelial Dysfunction","enrollment":85},{"nctId":"NCT03278548","phase":"PHASE4","title":"Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2017-09-28","conditions":"Hypovolaemia Due to Acute Blood Loss","enrollment":2289},{"nctId":"NCT06103214","phase":"NA","title":"The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery","status":"COMPLETED","sponsor":"Zhejiang Cancer Hospital","startDate":"2017-01-01","conditions":"Ovarian Neoplasm Epithelial","enrollment":144},{"nctId":"NCT05475990","phase":"NA","title":"Comparison of Hydroxyethyl Starch and Crystalloid Coload Combined With Norepinephrine Infusion for Hypotension","status":"COMPLETED","sponsor":"General Hospital of Ningxia Medical University","startDate":"2023-01-11","conditions":"Adverse Effect","enrollment":80},{"nctId":"NCT02192502","phase":"PHASE3","title":"Use of 6% Hydroxyethylstarch (130/0.4) in Cardiac Surgical Patients","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2015-03","conditions":"Postoperative Kidney Injury","enrollment":149},{"nctId":"NCT05133817","phase":"NA","title":"Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension","status":"COMPLETED","sponsor":"General Hospital of Ningxia Medical University","startDate":"2021-11-26","conditions":"Adverse Event","enrollment":175},{"nctId":"NCT05505708","phase":"EARLY_PHASE1","title":"a Comparison Between the Effects of Crystalloids and Colloids on Lung Ultrasound","status":"UNKNOWN","sponsor":"Kasr El Aini Hospital","startDate":"2022-12-05","conditions":"Pulmonary Edema","enrollment":44},{"nctId":"NCT05223361","phase":"PHASE3","title":"Cardiopulmonary Bypass Prime Solution in Patients Undergoing Heart Valve Surgery","status":"COMPLETED","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2016-04","conditions":"Heart Valve Diseases","enrollment":120},{"nctId":"NCT03252496","phase":"NA","title":"Combined Colloids And Crystalloids Versus Crystalloids in Women With Preeclampsia Undergoing Cesarean Delivery","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2017-08-19","conditions":"Pre-Eclampsia, Cesarean Section","enrollment":140},{"nctId":"NCT03262480","phase":"NA","title":"The Stroke Volume Optimization of Goal Directed Fluid Therapy During Radical Cystectomy","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2017-09-01","conditions":"Radical Cystectomy","enrollment":172},{"nctId":"NCT02584868","phase":"PHASE3","title":"Colloids in Pediatric Cardiac Surgery: Comparison Between a Balanced and a Non-balanced Colloid","status":"COMPLETED","sponsor":"Queen Fabiola Children's University Hospital","startDate":"2013-02-15","conditions":"Cardiac Surgery, Cardiopulmonary Bypass","enrollment":88},{"nctId":"NCT03222778","phase":"","title":"Combination of Static Echocardiographic Indices for Prediction of Fluid Responsiveness During Cardiac Surgery","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2017-12-01","conditions":"Fluid Responsiveness","enrollment":66},{"nctId":"NCT00964015","phase":"NA","title":"Starch or Saline After Cardiac Surgery","status":"TERMINATED","sponsor":"London Health Sciences Centre","startDate":"2009-08","conditions":"Coronary Artery Bypass Surgery","enrollment":69},{"nctId":"NCT02329158","phase":"","title":"Disinvestment in Hydroxyl-ethyl Starches (HES) for Cardiac Surgery","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2015-05","conditions":"Cardiac Surgical Procedures","enrollment":2000},{"nctId":"NCT01195883","phase":"NA","title":"Effect of Goal-directed Crystalloid Versus Colloid Administration on Major Postoperative Morbidity","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2010-11","conditions":"Postoperative Complications","enrollment":1102},{"nctId":"NCT03486600","phase":"NA","title":"Fluid Resuscitation With Hydroxyethyl Starch 130/0.4 in Trauma Patients","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2018-04-01","conditions":"Trauma","enrollment":392},{"nctId":"NCT03465943","phase":"EARLY_PHASE1","title":"Different Preloads for Prevention of Hypotension in Patients Undergoing Elective CS Under Intrathecal Anesthesia","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-03","conditions":"Hypotension Drug-Induced","enrollment":60},{"nctId":"NCT00517127","phase":"PHASE4","title":"Crystalloids Versus Colloids During Surgery","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2006-09","conditions":"Fluid Overload, Postoperative Complications","enrollment":1109},{"nctId":"NCT02961842","phase":"NA","title":"Combined Colloid Preload And Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2016-11-20","conditions":"Anesthesia, Spinal, Cesarean Section","enrollment":200},{"nctId":"NCT02622126","phase":"PHASE2","title":"Colloid Pre-Loading on D-Dimer During Cesarean Section Under Spinal Anesthesia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2016-01","conditions":"Coagulation Defect; Bleeding","enrollment":60},{"nctId":"NCT01402934","phase":"NA","title":"Pulse Pressure Variation in Spontaneously Breathing Patients","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2011-05","conditions":"Pulse Pressure Variation, Spontaneously Breathing","enrollment":70},{"nctId":"NCT02361736","phase":"NA","title":"Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery","status":"COMPLETED","sponsor":"Yuanyuan Zhang","startDate":"2015-03","conditions":"Total Fluid Volume Increased","enrollment":120},{"nctId":"NCT01303250","phase":"PHASE4","title":"Perioperative Colloid vs Crystalloid in Patients Undergoing Colorectal Surgery","status":"TERMINATED","sponsor":"University Hospital Muenster","startDate":"2011-04","conditions":"Surgery, Colorectal","enrollment":31},{"nctId":"NCT02393196","phase":"PHASE4","title":"Colloid Preload Versus Colloid Coload During Cesarean Deliveries","status":"UNKNOWN","sponsor":"Sifa University","startDate":"2015-03","conditions":"Anesthesia; Adverse Effect, Spinal and Epidural, Hypotension","enrollment":200},{"nctId":"NCT01818375","phase":"NA","title":"Goal Directed Fluid Therapy and Postoperative Ileus","status":"COMPLETED","sponsor":"Gabriele Baldini, MD, MSc, Assistant Professor","startDate":"2013-02","conditions":"Postoperative Ileus","enrollment":128},{"nctId":"NCT01874730","phase":"NA","title":"KOREAN Enhanced RecOvery Strategy for Colorectal Surgery","status":"TERMINATED","sponsor":"Duke University","startDate":"2013-07","conditions":"Goal-oriented Fluid Therapy, Colorectal Surgery","enrollment":101},{"nctId":"NCT02112409","phase":"NA","title":"Intraoperative Cell Salvage and Hemodilution Technique in Scoliosis Surgery","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2014-02","conditions":"Adolescent Idiopathic Scoliosis","enrollment":44},{"nctId":"NCT02459470","phase":"NA","title":"Stroke Volume Variation and Pulse Pressure Variation as Predictors of Fluid Responsiveness During Kidney Transplantation","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2012-12","conditions":"Kidney Transplantation","enrollment":42},{"nctId":"NCT01729364","phase":"NA","title":"Fluid Investigation Colloid vs Crystalloid Reg. Renal Hemodynamics and Function","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","startDate":"2008-04","conditions":"Renal Impairment","enrollment":30},{"nctId":"NCT02034682","phase":"NA","title":"The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2014-01","conditions":"Microvascular Reactivity, Tissue Oxygen Saturation","enrollment":40},{"nctId":"NCT01174719","phase":"PHASE4","title":"Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2006-03","conditions":"Valvular Heart Disease, Coronary Artery Disease","enrollment":240},{"nctId":"NCT01452581","phase":"NA","title":"Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty","status":"TERMINATED","sponsor":"Rigshospitalet, Denmark","startDate":"2011-10","conditions":"Arthroplasty, Hip","enrollment":5},{"nctId":"NCT02337010","phase":"NA","title":"Continuous Central Venous Oxygen Saturation Assisted Intraoperative Hemodynamic Management","status":"COMPLETED","sponsor":"Domonkos Trásy","startDate":"2010-10","conditions":"Major Abdominal Surgery, Perioperative Haemodynamic Monitoring, Perioperative Fluid Management","enrollment":79},{"nctId":"NCT02306213","phase":"NA","title":"Effect of Hydroxyethylstarch 6% 130/0.4 Administration on Renal Function After Cardiac Surgery","status":"COMPLETED","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2011-01","conditions":"Kidney Function Tests","enrollment":1564},{"nctId":"NCT01195025","phase":"NA","title":"Volume Kinetics for Starch Solution and Acetated Ringers","status":"COMPLETED","sponsor":"University Hospital, Linkoeping","startDate":"2010-08","conditions":"Blood Volume, Blood Coagulation","enrollment":10},{"nctId":"NCT01553617","phase":"PHASE4","title":"VolulyteTM in Cardiac Surgery","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2012-10","conditions":"Heart; Dysfunction Postoperative, Cardiac Surgery","enrollment":133},{"nctId":"NCT01689506","phase":"PHASE4","title":"Fluid Resuscitation in Patients Suffering From Burns Injury","status":"TERMINATED","sponsor":"Fresenius Kabi","startDate":"2012-12","conditions":"Burns","enrollment":11},{"nctId":"NCT02033213","phase":"NA","title":"Volume Restriction in Esophageal Carcinoma Surgery: Randomized Clinical Trial","status":"COMPLETED","sponsor":"Klinički Bolnički Centar Zagreb","startDate":"2011-06","conditions":"Esophageal Neoplasm","enrollment":16},{"nctId":"NCT02079350","phase":"","title":"Impact of %6 HES 130/0.4 and %4 Gelofusine Infusion on Kidney Function in the Living-donor Liver Transplantation","status":"COMPLETED","sponsor":"Turkiye Yuksek Ihtisas Education and Research Hospital","startDate":"2011-01","conditions":"Patients Undergoing Liver Transplantation","enrollment":36},{"nctId":"NCT01972828","phase":"NA","title":"Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2007-07","conditions":"Septic Shock","enrollment":61},{"nctId":"NCT00421200","phase":"PHASE3","title":"Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty","status":"COMPLETED","sponsor":"Sangart","startDate":"2007-02","conditions":"Hypotension, Ischemia","enrollment":375},{"nctId":"NCT00420277","phase":"PHASE3","title":"Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty","status":"COMPLETED","sponsor":"Sangart","startDate":"2007-02","conditions":"Hypotension, Ischemia","enrollment":462},{"nctId":"NCT00633659","phase":"PHASE2","title":"Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia","status":"COMPLETED","sponsor":"Sangart","startDate":"2007-09","conditions":"Vascular Disease, Critical Lower Limb Ischemia","enrollment":6},{"nctId":"NCT01840670","phase":"","title":"Central Venous and Abdominal Pressures and the Inferior Vena Cava","status":"UNKNOWN","sponsor":"Catholic University of the Sacred Heart","startDate":"2013-05","conditions":"Hypovolemia","enrollment":16},{"nctId":"NCT01758172","phase":"PHASE3","title":"Comparison of Hemodynamic Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2009-10","conditions":"Pancreaticoduodenectomy","enrollment":100},{"nctId":"NCT01652131","phase":"NA","title":"Behaviour of Intravenous Solutions in Obese Patients Under General Anesthesia","status":"UNKNOWN","sponsor":"National Institute of Medical Sciences and Nutrition, Salvador Zubiran","startDate":"2012-05","conditions":"Obesity, Obesity, Morbid","enrollment":12},{"nctId":"NCT00935168","phase":"PHASE3","title":"Crystalloid Versus Hydroxyethyl Starch Trials","status":"COMPLETED","sponsor":"The George Institute","startDate":"2009-12","conditions":"Intensive Care","enrollment":7000},{"nctId":"NCT00852449","phase":"PHASE4","title":"Intraoperative Hypovolemia and Fluid Therapy","status":"TERMINATED","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2008-05","conditions":"Hypovolemia, Organ Dysfunction","enrollment":70},{"nctId":"NCT01670604","phase":"PHASE4","title":"Use of Two Modern Hydroxyethyl Starch Solutions in Major Urological Procedures","status":"UNKNOWN","sponsor":"Kasr El Aini Hospital","startDate":"2012-01","conditions":"Urologic Surgical Procedures","enrollment":40},{"nctId":"NCT01654653","phase":"PHASE4","title":"Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients","status":"COMPLETED","sponsor":"Innogene Kalbiotech Pte. Ltd","startDate":"2008-07","conditions":"Coronary Heart Disease","enrollment":100},{"nctId":"NCT01644084","phase":"NA","title":"A Comparison Between 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 in Priming Solution for Cardiopulmonary Bypass and Post-bypass Maintenance Fluid in High-risk Patients","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2009-06","conditions":"Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass","enrollment":54},{"nctId":"NCT00962156","phase":"PHASE3","title":"Scandinavian Starch for Severe Sepsis/Septic Shock Trial","status":"COMPLETED","sponsor":"Anders Perner","startDate":"2009-12","conditions":"Severe Sepsis, Septic Shock","enrollment":804},{"nctId":"NCT01127477","phase":"PHASE3","title":"Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective Surgery","status":"COMPLETED","sponsor":"Fresenius Kabi Japan","startDate":"2010-05","conditions":"Plasma Volume Substitution (Hypovolemia) Including Massive Hemorrhage","enrollment":20},{"nctId":"NCT00694343","phase":"PHASE4","title":"Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2008-06","conditions":"Hypotension","enrollment":167},{"nctId":"NCT00978588","phase":"NA","title":"Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2008-02","conditions":"Mitral Valvular Heart Disease","enrollment":36},{"nctId":"NCT00464204","phase":"PHASE3","title":"Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2007-07","conditions":"Sepsis","enrollment":196},{"nctId":"NCT01301469","phase":"PHASE3","title":"Comparison of HES 130 in Balanced and in Unbalanced Solution","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2011-02","conditions":"Decreased and Nonspecific Blood Pressure Disorders and Shock","enrollment":240},{"nctId":"NCT00860405","phase":"PHASE4","title":"Voluven® in Paediatric Patients","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2009-03","conditions":"Cardiac Surgery, Cardiopulmonary Bypass","enrollment":61},{"nctId":"NCT00273728","phase":"PHASE4","title":"BaSES Trial: Basel Starch Evaluation in Sepsis","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2005-05","conditions":"Sepsis, Severe Sepsis, Septic Shock","enrollment":231},{"nctId":"NCT01012648","phase":"PHASE4","title":"Early Fluid Resuscitation With Balanced HES 130/0.4 [6%] in Severe Burn Injury","status":"UNKNOWN","sponsor":"University of Zurich","startDate":"2009-11","conditions":"Burns","enrollment":48},{"nctId":"NCT01010022","phase":"PHASE3","title":"Trial of 6% HES130/0.4","status":"COMPLETED","sponsor":"Fresenius Kabi Japan","startDate":"2009-11","conditions":"Hypovolemia, Hemorrhage","enrollment":64},{"nctId":"NCT01041742","phase":"NA","title":"Pulse Pressure Variation (PPV) to Predict Fluid Responsiveness During Cardiac Displacement in Patients Undergoing Off-pump Coronary Artery Bypass Surgery (OPCAB)","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2009-12","conditions":"Ischemic Heart Disease","enrollment":35},{"nctId":"NCT01051206","phase":"PHASE4","title":"The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2009-05","conditions":"Coronary Artery Occlusive Disease","enrollment":106},{"nctId":"NCT00576849","phase":"PHASE4","title":"A Total Balanced Volume Replacement Regimen in Elderly Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Klinikum Ludwigshafen","startDate":"2007-12","conditions":"Elderly, Cardiac Surgery","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Any volume therapy has been recorded"],"phase":"marketed","status":"active","brandName":"Hydroxyethylstarch 6% 130/0.4","genericName":"Hydroxyethylstarch 6% 130/0.4","companyName":"Medical University of Vienna","companyId":"medical-university-of-vienna","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Hydroxyethylstarch (HES) 6% 130/0.4 is a synthetic colloid that expands intravascular volume by increasing plasma oncotic pressure and maintaining fluid in the vascular space. Used for Acute hypovolemia and restoration of circulating blood volume in perioperative and critical care settings.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}